← Browse by Condition
Medical Condition
relapse recurrence
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT04984837 Phase 2
Recruiting
Study of Lacutamab in Peripheral T-cell Lymphoma
Enrollment
56 pts
Location
Belgium, France, Ger...
Sponsor
The Lymphoma Academic Research...
NCT06713837 Phase 3
Recruiting
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Enrollment
339 pts
Location
Czechia, Germany, It...
Sponsor
Istituto Romagnolo per lo Stud...